These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 33802143)

  • 1. Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial.
    Clavo B; Martínez-Sánchez G; Rodríguez-Esparragón F; Rodríguez-Abreu D; Galván S; Aguiar-Bujanda D; Díaz-Garrido JA; Cañas S; Torres-Mata LB; Fabelo H; Téllez T; Santana-Rodríguez N; Fernández-Pérez L; Marrero-Callico G
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ozone in Chemotherapy-Induced Peripheral Neuropathy-Current State of Art, Possibilities, and Perspectives.
    Szklener K; Rudzińska A; Juchaniuk P; Kabała Z; Mańdziuk S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
    Schloss J; Colosimo M; Vitetta L
    Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Kuriyama A; Endo K
    Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.
    Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M
    Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
    Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
    BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca
    Karlsson JOG; Jynge P
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings.
    Ibrahim EY; Ehrlich BE
    Crit Rev Oncol Hematol; 2020 Jan; 145():102831. PubMed ID: 31783290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis.
    Wu S; Bai X; Guo C; Huang Z; Ouyang H; Huang J; Zeng W
    BMC Cancer; 2021 Nov; 21(1):1173. PubMed ID: 34727879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
    Kachrani R; Santana A; Rogala B; Pawasauskas J
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidants Improve Oxaliplatin-Induced Peripheral Neuropathy in Tumor-Bearing Mice Model: Role of Spinal Cord Oxidative Stress and Inflammation.
    Agnes JP; Santos VWD; das Neves RN; Gonçalves RM; Delgobo M; Girardi CS; Lückemeyer DD; Ferreira MA; Macedo-Júnior SJ; Lopes SC; Spiller F; Gelain DP; Moreira JCF; Prediger RD; Ferreira J; Zanotto-Filho A
    J Pain; 2021 Aug; 22(8):996-1013. PubMed ID: 33774154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
    Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
    Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy.
    Areti A; Yerra VG; Naidu V; Kumar A
    Redox Biol; 2014; 2():289-95. PubMed ID: 24494204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy.
    Zajączkowska R; Kocot-Kępska M; Leppert W; Wrzosek A; Mika J; Wordliczek J
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.
    Bakogeorgos M; Georgoulias V
    Expert Rev Anticancer Ther; 2017 Nov; 17(11):1045-1060. PubMed ID: 28868935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations.
    Gewandter JS; Brell J; Cavaletti G; Dougherty PM; Evans S; Howie L; McDermott MP; O'Mara A; Smith AG; Dastros-Pitei D; Gauthier LR; Haroutounian S; Jarpe M; Katz NP; Loprinzi C; Richardson P; Lavoie-Smith EM; Wen PY; Turk DC; Dworkin RH; Freeman R
    Neurology; 2018 Aug; 91(9):403-413. PubMed ID: 30054438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.
    Schloss JM; Colosimo M; Airey C; Masci PP; Linnane AW; Vitetta L
    Clin Nutr; 2013 Dec; 32(6):888-93. PubMed ID: 23647723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
    Wolf S; Barton D; Kottschade L; Grothey A; Loprinzi C
    Eur J Cancer; 2008 Jul; 44(11):1507-15. PubMed ID: 18571399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.